Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Embody vs Vitalex Health

Embody
Graded #52

Higher grade

vs+16.5
Vitalex Health
Graded #338

Lower grade

The verdict

Embody takes it — 76.2/100 to 59.7/100.

Embody grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEmbody +33
87
54
Dose & formulationEmbody +19
83
64
Clinical oversightEmbody +19
83
64
Labs & monitoringEmbody +2
54
52
FulfillmentEmbody +23
93
70
Contract termsVitalex Health +30
25
55
Embody · left barVitalex Health · right bar

The numbers

MetricEmbodyVitalex Health
WeighScore76.2/10059.7/100
GradeCC
Scorecard rank#52#338
Semaglutide$79/mo (all doses, promotional rate, compounded)$199/mo (starting dose, compounded)
Tirzepatide$129/mo (all doses, promotional rate, compounded)$199/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Embody

Graded #52 · C

Strengths

  • Among the lowest flat rates in the compounded segment — $79/mo semaglutide and $129/mo tirzepatide injection at every dose
  • Unique compounded oral tirzepatide gum formulation — alternative for patients who prefer not to inject
  • Available in all 50 states with no insurance friction
  • 24/7 unlimited clinician messaging and dose-adjustment support included
  • Medical leadership by Dr. Alan Viglione, board-certified in Internal Medicine

Where it loses points

  • The $79 flat rate relies on an auto-applied promo 'locked forever' — list price in the terms is $199/mo and reviewers allege the lock isn't honored
  • Compounded only — no FDA-approved brand-name Ozempic, Wegovy, Zepbound, or Mounjaro option
  • Pharmacy partners not publicly named — compounding source transparency is limited
  • Compounded oral tirzepatide does not have an FDA-approved counterpart, and oral GLP-1 bioavailability remains an active area of clinical debate
Vitalex Health

Graded #338 · C

Strengths

  • Flat-rate pricing starting at $199/mo with no consultation fee or dose-change surcharges
  • Three distinct programs — Semaglutide, Tirzepatide, and a lower-dose GLP-1 Microdose protocol for body composition
  • Names its legal entity (Vitalex Health, LLC), a real street address, phone number, and posted clinical hours
  • Named lead clinician (Laqueta Nelson, MSN, FNP-BC) instead of an anonymous care team
  • Working Terms of Service, Privacy Policy, and HIPAA Notice pages, not dead links

Where it loses points

  • Brands itself “physician-led” sitewide, but the only named clinician is a nurse practitioner (FNP-BC), not a physician
  • No LegitScript seal or other third-party pharmacy-verification badge found anywhere on the site
  • Compounding pharmacy and prescribing medical group are referenced only generically — neither is named
  • Exact price is not published — the $199/mo figure is only a starting point confirmed after provider review
  • Domain was registered in April 2026 — a brand-new practice with no independent reviews found

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard